|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.0700 - 1.1350|
|52 Week Range||0.8498 - 3.2800|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Toronto, Ontario--(Newsfile Corp. - September 18, 2019) - Capital 10X President Evan Veryard sits down with Khiron Life Sciences (TSXV: KHRN) CEO Alvaro Torres.They discuss Khiron's Colombian operations, expansion plans, and whether Khiron is on track to meet analyst expectations.Cannot view this video? Visit:https://capital10x.com/khiron-khrn-ceo-alvaro-torres-colombia-operations/For more information, please contact:Capital 10XEvan Veryard, President416-571-9037To view the source version of this press release, please visit https://www.newsfilecorp.com/release/47907
Market research and cannabis consultancy company Brightfield Group on Tuesday released a report analyzing the current state of the Latin American cannabis market. The report focuses on looking at each country’s legislation, to assess their potential consumer markets. Too Green For The Green Rush? The report analyses the situation of the cannabis industry in Chile, Mexico, Colombia, Brazil, Argentina, Peru and Uruguay.
/R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/
TORONTO, Sept. 10, 2019 /PRNewswire/ -- Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that Khiron CEO, Alvaro Torres will present life at VirtualInvestorConferences.com on September 12th. Received conditional TSXV Approval for roll-out of Kuida Cosmeceutical Line in U.S. market and cannabis-infused products in Latin America.
Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...
On Aug. 20, the United Nations International Narcotics Control Board (“INCB”) announced that Colombia would be awarded a quota of 1.2 tons of cannabis oil for internal medicinal and scientific use. This substantially reduced number compares to the 2018 quota of 47 tons, which caused euphoria and champagne corks to fly from bottles throughout the LATAM Andes, all the way to Canadian stock exchanges. Colombian and international media (not surprisingly) announced that this new limited quota represented a “fatal blow” to its cannabis industry.
TORONTO, Sept. 4, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, announced today that it has commenced construction of a 9,800 m2 (105,486 sq.ft) cultivation and processing facility in Juan Lacaze, Uruguay. With a production capacity of 17 tons per year, the Company's investment in this state-of-the-art facility represents a significant increase in Khiron's total production capacity, strengthening its ability to export and supply cannabis to key international markets, including Brazil and Europe.
Seniors identified among the fastest growing adopters of medical cannabis (Source: University of Colorado ) Over 1 million patients in Colombia are elderly and suffer from chronic pain, anxiety, depression ...
State-of-the-art, 14,000 square foot GMP compliant cannabis extraction lab and ISO 17025 compliant cannabis testing lab includes full capabilities in Ultra high and High performance liquid chromatography ...
TORONTO, Aug. 20, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, announced today that its shares have received Depository Trust Company (DTC) full-service eligibility in the United States. DTC eligibility is expected to simplify the process of trading and transferring of the Company's common shares in the United States.
TORONTO, Aug. 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), an integrated cannabis company with core operations in Latin America, wishes to clarify specific disclosure relating to the news release disseminated by the Company on August 12, 2019. Khiron Life Sciences Corp. is positioned to be the dominant integrated cannabis company in Latin America. Khiron has core operations in Latin America and is fully licensed in Colombia for the cultivation, production, domestic distribution, and international export of both tetrahydrocannabinol (THC) and cannabidiol (CBD) medical cannabis.
Experienced capital markets leader and cannabis industry executive Tejinder Virk is appointed President of Khiron Europe Accomplished cannabis legal expert Franziska Katterbach joins Company as Chief Legal ...
Grupo Éxito has a multinational retail presence in Colombia , Brazil , Argentina and Uruguay and operates 1,533 stores. Kuida to be introduced as key addition to the retailer's cosmetics products category, with experience centres and consultants in each Éxito WOW store to support sales and brand awareness.